Skip to content
Discover insightful articles on contemporary culture, socia…

Zimbabwe Turns Down ‘Lopsided’ American Health Aid Package Due to Information Apprehensions

Medical aid image
The offered US funding would have supported initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a major US health deal valued at 367 million US dollars (£272m) over five years due to the United States' demand for confidential biological samples.

The decision became public following a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".

A government spokesman has since clarified that the US was requesting biological samples for research and profit but was unwilling to guarantee the resulting advantages from any future vaccines.

"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged continued dialogue to secure a agreement acceptable to all parties so the nation's vital HIV treatment initiative can continue.

Wider Context

This development comes after a comparable situation in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were raised about the security of citizens' health data.

Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.

The agency had overseen aid for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government deals to boost openness and responsibility.

Based on reports, Sixteen nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.

Specifics of the Rejected Agreement

The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to share its biological resources and data indefinitely, without any corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"In essence, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our people should a new health crisis emerge."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting systems previously set up through the global organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.

"This framework is designed to guarantee that when a country provides its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to develop them."

Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.

"We are open to ongoing dialogue with our US partners on how future collaboration might be arranged in a way that honours the sovereignty and dignity of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that negotiations should continue given that much of the country's HIV programmes were funded by international support.

"Where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," the group added.

This impasse emphasises the ongoing challenges between accepting much-needed international aid and protecting a country's data in an ever more interconnected world.

About the author

Sherri Sutton

A cultural anthropologist and writer passionate about documenting societal shifts and their impact on everyday life.

Chronicle Society Blog

Type to search articles.